Canada markets closed

Oncternal Therapeutics, Inc. (ONCT)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
8.66-0.17 (-1.93%)
At close: 04:00PM EDT
8.51 -0.44 (-4.93%)
After hours: 04:12PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 26.12M
Enterprise Value -630.13k
Trailing P/E 2.11
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.14
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.36
52-Week Change 342.26%
S&P500 52-Week Change 326.36%
52 Week High 313.20
52 Week Low 35.57
50-Day Moving Average 38.65
200-Day Moving Average 37.80

Share Statistics

Avg Vol (3 month) 37.07k
Avg Vol (10 day) 34.03k
Shares Outstanding 52.96M
Implied Shares Outstanding 62.96M
Float 82.71M
% Held by Insiders 19.23%
% Held by Institutions 115.57%
Shares Short (Apr 30, 2024) 412.95k
Short Ratio (Apr 30, 2024) 42.11
Short % of Float (Apr 30, 2024) 40.45%
Short % of Shares Outstanding (Apr 30, 2024) 40.44%
Shares Short (prior month Mar 28, 2024) 416.73k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jun 10, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Jan 08, 2024

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,542.88%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)1.15M
Revenue Per Share (ttm)0.39
Quarterly Revenue Growth (yoy)180.30%
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-36.38M
Diluted EPS (ttm)-12.33
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)34.26M
Total Cash Per Share (mrq)11.57
Total Debt (mrq)318k
Total Debt/Equity (mrq)1.06%
Current Ratio (mrq)N/A
Book Value Per Share (mrq)10.19

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A